Malaria antibody prevents infection in infants but interferes with vaccine
A new trial in Mali shows a monoclonal antibody protects babies against malaria, but combining it with a malaria vaccine causes unexpected interference.
FTMQ Health, written by our newsroom0 views

Researchers testing a monoclonal antibody against malaria found that the treatment successfully protects infants, but it interferes with a malaria vaccine when given together. STAT News reported on Thursday that scientists evaluated the monoclonal antibody, known as L9LS, in a clinical trial involving infants in Mali. [1]
The trial demonstrated that a single injection of L9LS was 78 percent effective at protecting infants against the malaria parasite compared to a placebo. Public health experts had hoped that monoclonal antibodies could offer several months of protection to young children before they are old enough to begin standard malaria vaccination schedules. [1]
The findings cast doubt on strategies that combine antibody shots with active immunization. As FTMQ Health reported earlier, existing preventive measures include seasonal mass administration of the R21 malaria vaccine, which reduced infection odds by up to 70 percent in trials conducted in Burkina Faso and The Gambia. [1][3]
In short
- The L9LS monoclonal antibody was 78 percent effective against malaria compared to a placebo in a trial of infants in Mali.
- Researchers discovered that the monoclonal antibody interfered with a malaria vaccine when given to babies.
- A single injection of the monoclonal antibody is designed to provide several months of defense against the parasite.
Sources
Every paragraph above points to the numbered items it rests on. Read the originals here.
- [1]Study raises doubts about combining vaccine, monoclonal antibody to protect against malariaSTAT News, 1d ago (the report this story comes from)
Background
- [2]Anti-vaccine activism on Wikipedia
- [3]Seasonal mass vaccination with R21 vaccine cuts malaria infection risk FTMQ Health, 1d ago
Our newsroom writes these reports with the help of software, from the 3 sources listed and nothing else, and checks them against those sources. Facts can still be wrong or move on; the originals are the record. Spotted a mistake? Write to daniel@monsterkong.com.
Related from FTMQ Health
Earlier reports of ours on the same people and subjects.
- Seasonal mass vaccination with R21 vaccine cuts malaria infection riskTop Stories, 1d ago
- Trial in Mali tests azithromycin impacts on infant antimicrobial resistanceMedical Science, 7d ago
- International trial tests oral bacterial lysate to prevent infant wheezeMedical Science, 8d ago
- Study finds high co-infection rates among malaria patients in PeshawarMedical Science, 15h ago
- Infectious disease expert highlights rising serogroup Y meningococcal infectionsPublic Health, 38d ago
More in Top Stories
- United Therapeutics performs first UThymoKidney transplant in EXTEND trial15h ago
- Princeton neuroscience researcher detained by ICE following conference15h ago
- FDA rejects Capricor Therapeutics Duchenne muscular dystrophy cell therapy15h ago
- Northern Ireland ambulance service misses two-hour target over 2,000 times1d ago
- Senior surgeon calls for police investigation into Scottish hospital patient deaths1d ago
- Seasonal mass vaccination with R21 vaccine cuts malaria infection risk1d ago
Get the day in one email
Reports like this one, the top news of the last 24 hours, every morning. Free, one email a day; readers can comment under every report.
By signing up you agree to our terms and privacy policy. Unsubscribe any time.

Comments
Loading
Join the conversation
Comments are open to readers of our daily email: the top news of the last 24 hours, every morning, free. Sign up and the comment box opens.
Already on the list? Enter the same address and we will send a sign-in link.
By signing up you agree to our terms and privacy policy. Unsubscribe any time.